Yew Bio-Pharm Group, Inc. (YEWB) financial statements (2022 and earlier)

Company profile

Business Address 9460 TELSTAR AVENUE, SUITE 6
EL MONTE, CA 91731
State of Incorp. NV
Fiscal Year End December 31
SIC 01 - Agricultural Production Crops (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 564742522860279682
Cash and cash equivalents 564742522860279682
Restricted cash and investments      304
Receivables 2748,0421,00311,60923,06611,047
Inventory, net of allowances, customer advances and progress billings 152,6376,2052,57910,2974,666
Inventory 152,6376,2052,57910,2974,666
Other undisclosed current assets 9,1372504,66020,386152171
Total current assets: 9,98911,67112,38935,43433,79316,868
Noncurrent Assets
Inventory, Noncurrent 7851,5801,82410,5477,15212,334
Operating lease, right-of-use asset 333400
Property, plant and equipment 489475519580692703
Long-term investments and receivables  1,185930   
Due from related parties  1,185930   
Intangible assets, net (including goodwill), including: 2832456,3704,55813,906
Intangible assets, net (excluding goodwill) 2840,04934,9156,3704,55813,906
Other undisclosed intangible assets, net (including goodwill)  (40,016)(34,869)   
Other undisclosed noncurrent assets 46,82238,86433,985   
Total noncurrent assets: 48,45742,53537,30317,49612,40226,943
TOTAL ASSETS: 58,44754,20749,69252,93046,19543,811
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 424248458163379125
Accounts payable 424132268   
Accrued liabilities      80
Employee-related liabilities      45
Taxes payable  116190617 
Other undisclosed accounts payable and accrued liabilities    157363 
Debt 8,9808,5945,7596,1002,8803,688
Due to related parties 651634580620884761
Other undisclosed current liabilities 4701,0062655163,35567
Total current liabilities: 10,52510,4817,0627,3997,4984,641
Noncurrent Liabilities
Long-term debt and lease obligation 292351    
Operating lease, liability 292351
Liabilities, other than long-term debt 2,147892 360121 
Deferred revenue and credits360121 
Accounts payable and accrued liabilities 974     
Deferred revenue 1,173892
Other undisclosed noncurrent liabilities  1,0881,543   
Total noncurrent liabilities: 2,4392,3321,543360121 
Total liabilities: 12,96412,8138,6057,7587,6194,641
Stockholders' equity
Stockholders' equity attributable to parent, including: 45,48341,39441,08745,17238,57639,170
Common stock 525252525252
Additional paid in capital 9,6459,8209,95310,3639,6549,623
Accumulated other comprehensive income (loss) 608(2,191)(1,646)707(1,967)666
Retained earnings 31,41629,95128,96530,28827,07525,068
Other undisclosed stockholders' equity attributable to parent 3,7623,7623,7623,7623,7623,762
Total stockholders' equity: 45,48341,39441,08745,17238,57639,170
TOTAL LIABILITIES AND EQUITY: 58,44754,20749,69252,93046,19543,811

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 27,30827,88437,59740,54051,34829,574
Revenue, net40,54051,34829,574
Revenue from related parties 26,41817,85037,166
Cost of revenue (23,781)(27,110)(26,873)(35,478)(48,114)(22,541)
Cost of goods and services sold  (10,003)(1,241)(17,811)(24,689)(11,104)
Gross profit: 3,52777410,7245,0623,2357,033
Operating expenses (958)237(10,006)(1,737)(1,113)(1,893)
Operating income: 2,5691,0127193,3252,1215,140
Nonoperating income (expense) (1,075)(15)(548)(111)(96)161
Investment income, nonoperating    148  
Foreign currency transaction gain (loss), before tax (608)318(338)   
Other nonoperating income (expense) 155784(34)440
Interest and debt expense (482)(390)(294)   
Other undisclosed income from continuing operations before equity method investments, income taxes      1,279
Income (loss) from continuing operations before equity method investments, income taxes: 1,012606(123)3,2142,0256,580
Other undisclosed income (loss) from continuing operations before income taxes 482390294  (1,279)
Income from continuing operations before income taxes: 1,4949971713,2142,0255,301
Income tax expense (29)(11)(1,493)(1)(18)(16)
Net income (loss) available to common stockholders, diluted: 1,465986(1,322)3,2132,0075,285

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): 1,465986(1,322)3,2132,0075,285
Comprehensive income (loss): 1,465986(1,322)3,2132,0075,285
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 2,799(545)(2,353)2,673(2,632)(2,081)
Comprehensive income (loss), net of tax, attributable to parent: 4,264441(3,675)5,886(625)3,204

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: